An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)

  • Mariko DeWire, Maryam Fouladi, David C. Turner, Cynthia Wetmore, Cynthia Hawkins, Carmen Jacobs, Ying Yuan, Diane Liu, Stewart Goldman, Paul Fisher, Michael Rytting, Eric Bouffet, Yasmin Khakoo, Eugene I. Hwang, Nicholas Foreman, Clinton F. Stewart, Mark R. Gilbert, Richard Gilbertson, Amar Gajjar
  • Journal of Neuro-Oncology, April 2015, Springer Science + Business Media
  • DOI: 10.1007/s11060-015-1764-7

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1007/s11060-015-1764-7